NLRP3 and metabolic dysfunction-associated steatotic liver disease: Emerging evidence supports the central role of NLRP3 inflammasomes in the pathogenesis of many liver diseases, including alcoholic and nonalcoholic fatty liver disease as well as liver injury [19, 32–34].